COMBIMATRIX ! Unentdeckte Vogelgrippe-Aktie ! - 500 Beiträge pro Seite
eröffnet am 02.10.05 12:46:06 von
neuester Beitrag 20.02.06 18:32:46 von
neuester Beitrag 20.02.06 18:32:46 von
Beiträge: 14
ID: 1.010.976
ID: 1.010.976
Aufrufe heute: 0
Gesamt: 3.082
Gesamt: 3.082
Aktive User: 0
Top-Diskussionen
Titel | letzter Beitrag | Aufrufe |
---|---|---|
vor 1 Stunde | 421 | |
vor 45 Minuten | 135 | |
gestern 19:02 | 114 | |
gestern 21:36 | 79 | |
gestern 23:08 | 74 | |
vor 24 Minuten | 73 | |
gestern 23:36 | 68 | |
vor 22 Minuten | 60 |
Meistdiskutierte Wertpapiere
Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
---|---|---|---|---|---|---|---|
1. | 1. | 18.503,00 | +0,34 | 294 | |||
2. | 2. | 174,25 | -2,00 | 108 | |||
3. | 3. | 10,230 | +447,06 | 108 | |||
4. | 4. | 0,1935 | +2,38 | 77 | |||
5. | 7. | 0,9600 | -14,29 | 70 | |||
6. | 5. | 4,1725 | -5,17 | 64 | |||
7. | 6. | 1,1100 | -3,48 | 60 | |||
8. | 8. | 5,9840 | -1,55 | 48 |
" CombiMatrix Inc., a U.S. biotechnology company which is part of Acacia Research Corp., has produced dozens of molecules that could eventually be used in drugs to fight the SARS epidemic."
Quelle: http://www.newsmax.com/archives/articles/2003/5/9/132657.sht…
Quelle: http://www.newsmax.com/archives/articles/2003/5/9/132657.sht…
Was hat das nun mit der Vogelgrippe zu tun?
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Sept. 28 , 2005--Acacia Research Corporation (Nasdaq:CBMX - News; Nasdaq:ACTG - News) today announced its CombiMatrix Group has received a one year ($338,000) contract from the U.S. Air Force for the development and production of microarrays to detect pathogens that cause upper respiratory infections and pathogens that infect wounds. This contract is the result of a collaborative effort with the Air Force Institute of Occupational Health (AFIOH) that led to the development of a rapid assay and microarray that identifies all forms (serotypes) of influenza A, including bird flu. The first array to be developed under the new contract will identify a number of upper respiratory infections that can cause potentially life threatening diseases (viral and bacterial pneumonia) or lead to pandemic infections (bird flu and SARS).
Quelle: http://biz.yahoo.com/bw/050928/285187.html?.v=1
Quelle: http://biz.yahoo.com/bw/050928/285187.html?.v=1
"Going forward, we hope to continue expanding our work in areas of interest to our military and national security. These programs include our work with the DOD on a broad detection system for pathogens, our early pre-clinical work on compounds to treat acute exposure to radiation, and now this program with the U.S. Air Force," said Dr. Amit Kumar, President and CEO, of CombiMatrix. "We will continue to monitor the needs of our government as well as corresponding funding opportunities including BioShield ." http://biz.yahoo.com/bw/050928/285187.html?.v=1
Viele Vogelgrippeaktien haben schon stark performed. Du meinst, dass Combimatrix den Hype noch vor sich hat?
Wie mcmoneysac gesagt hat, wurde der Kurs aufgrund von Verkäufen an Investoren tief gehalten.
Viele Investoren sind frustriert, weil der Kurs so tief. Viele sind vermutlich ausgestiegen. Dabei ist der Grund einfach.
Friday, September 16, 2005
NEWPORT BEACH--- CombiMatrix Group to Receive $10.5 Million from Acacia Research Registered Direct Offering
Posted: 9/16/2005 @ 6:47 AM
Acacia Research Corporation (Nasdaq:CBMX)(Nasdaq:ACTG) today announced that it has obtained commitments to purchase approximately $10.5 million of its Acacia Research-CombiMatrix common stock in a registered direct offering. Under the terms of the transaction, Acacia will sell approximately 6.4 million shares of its Acacia Research-CombiMatrix common stock at $1.65 per share to a select group of accredited investors and grant to such investors five year warrants for the purchase of an aggregate of approximately 1.6 million shares of common stock at an exercise price of $2.40 per share . Piper Jaffray & Co. Acted as exclusive placement agent for the transaction.
NEWPORT BEACH--- CombiMatrix Group to Receive $10.5 Million from Acacia Research Registered Direct Offering
Posted: 9/16/2005 @ 6:47 AM
Acacia Research Corporation (Nasdaq:CBMX)(Nasdaq:ACTG) today announced that it has obtained commitments to purchase approximately $10.5 million of its Acacia Research-CombiMatrix common stock in a registered direct offering. Under the terms of the transaction, Acacia will sell approximately 6.4 million shares of its Acacia Research-CombiMatrix common stock at $1.65 per share to a select group of accredited investors and grant to such investors five year warrants for the purchase of an aggregate of approximately 1.6 million shares of common stock at an exercise price of $2.40 per share . Piper Jaffray & Co. Acted as exclusive placement agent for the transaction.
test
jedenfalls steht das in einem Yahooboard und die Aktie dreht wunderbar.
vergesst nicht biota !!!!!!!!!!!!!!
Wird Zeit, daß wieder etwas Schwung in den Kurs kommt.
Huch!
Jetzt sind wir aber schon 10% über Nasdaq-pari!
Jetzt sind wir aber schon 10% über Nasdaq-pari!
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
294 | ||
108 | ||
108 | ||
77 | ||
70 | ||
64 | ||
60 | ||
48 | ||
45 | ||
44 |
Wertpapier | Beiträge | |
---|---|---|
33 | ||
28 | ||
27 | ||
27 | ||
25 | ||
21 | ||
21 | ||
20 | ||
18 | ||
18 |